Aromatase Plus GnRH Analogue Versus Ulippristal Acetate in Uterine Fibroids
Status:
Unknown status
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
With this study the investigators want to test which is the best medical treatment for
symptomatic uterine fibroid, mostly abnormal uterine bleeding, between Ulipristal acetate
versus Aromatase inhibitor plus GnRH analog, in term of uterine and fibroid volume reduction
Phase:
Phase 4
Details
Lead Sponsor:
Centre for Endocrinology and Reproductive Medicine, Italy